Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 12, 2016 - Issue
Submit an article Journal homepage
125
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

Caitlyn T Solem1 Pharmerit International, Real World Evidence/Data Analytics, Bethesda, MDCorrespondence[email protected]
,
Ahmed Shelbaya2 Pfizer, Inc., Global Health Outcomes, New York, NY;3 Epidemiology Department of Mailman’s School of Public Health, Columbia University Mailman School of Public Health, New York, NY, USA
,
Yin Wan1 Pharmerit International, Real World Evidence/Data Analytics, Bethesda, MD
,
Chinmay G Deshpande1 Pharmerit International, Real World Evidence/Data Analytics, Bethesda, MD
,
Jose Alvir2 Pfizer, Inc., Global Health Outcomes, New York, NY
&
Elizabeth Pappadopulos2 Pfizer, Inc., Global Health Outcomes, New York, NY
Pages 2755-2764 | Published online: 25 Oct 2016

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Dominic Pilon, Swapna Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté-Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefebvre, Kruti Joshi & Leslie Citrome. (2021) Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy. Journal of Medical Economics 24:1, pages 1299-1308.
Read now
Pierre Blier, Howard C. Margolese, E Adriana Wilson & Matthieu Boucher. (2019) Switching medication products during the treatment of psychiatric illness. International Journal of Psychiatry in Clinical Practice 23:1, pages 2-13.
Read now
Genevieve Gauthier, Lisa Mucha, Sherry Shi & Annie Guerin. (2019) Economic burden of relapse/recurrence in patients with major depressive disorder. Journal of Drug Assessment 8:1, pages 97-103.
Read now

Articles from other publishers (4)

Khalid Saad Alharbi. (2023) Anticonvulsant effects of desvenlafaxine on modulating brain monoamine and oxidative stress in mice. Brazilian Journal of Biology 83.
Crossref
Narcís Cardoner, Antoni Sicras-Mainar, Javier Rejas & Beatriz Armada. (2021) Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study. Clinical Drug Investigation 41:12, pages 1055-1066.
Crossref
A. Sicras-Mainar & A. Sicras-Navarro. (2021) Persistencia al tratamiento con metformina de marca vs. genérica en monoterapia para la diabetes tipo 2: estudio retrospectivo de vida real mediante propensity score matching. Medicina de Familia. SEMERGEN 47:5, pages 321-331.
Crossref
Elisabeth Kap, Marcel Konrad & Karel Kostev. (2019) Persistence with selective serotonin (norepinephrine) reuptake inhibitors in Germany—A retrospective database analysis. Journal of Affective Disorders 247, pages 156-160.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.